Source link : https://newshealth.biz/health-news/novel-drug-impresses-in-metastatic-pancreatic-cancer/
SAN DIEGO — Two phase I/II studies showed that the investigational RAS(ON) inhibitor daraxonrasib had a manageable safety profile and demonstrated promising efficacy both in combination with chemotherapy and as monotherapy in patients with previously untreated metastatic pancreatic cancer. Among 40 patients treated with daraxonrasib plus gemcitabine and nab-paclitaxel, the confirmed objective response rate (ORR) […]
The post Novel Drug Impresses in Metastatic Pancreatic Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2026-04-24 15:47:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8